GSK and Vir step up virus antibody treatment trials

GSK and Vir step up virus antibody treatment trials

LONDON,  – British pharmaceutical giant GlaxoSmithKline (GSK) and Californian laboratory Vir Biotechnology on Tuesday announced final stage testing of